Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
SSN
1:15AM Samson Oil & Gas enters 3-way Joint Venture for Hawk Springs Project (SSN) 1.99 : Co announces that it has entered into a three-party participation agreement with Halliburton Energy Services (a unit of HAL) and its existing private co partner for the evaluation and development of the Niobrara Formation and other conventional targets in the northern Denver-Julesburg Basin for part of co's Hawk Springs Project. Co and its partner will be free carried through the drilling and completion of two wells with ~4,500' laterals and will be reimbursed for a portion of the cost of the North Platte 3-D seismic survey. Halliburton will acquire 25% equity in the farm-in area (a net 2,819 acres). The transaction has been structured such that the acquisition cost can be valued at a rate of $3,275 per acre.
FDA holiday funk as far as I can tell. I hold shares and therefore expect approval to be the end result.
Here's another possible "reason" for the delay:
Quest is fully aware that you don't introduce a test to replace the PSA without being 100% sure that it'll do just that.
I agree that HDVY can crow all they want about the success of the urine test, but at the end of the day, it's Quest who is putting their reputation and money on the line.
Original guidelines for approval of the urine test were PR'ed by HDVY, not Quest. To my knowledge, Quest has never issued any guidance for completion and commercialization of the urine test. Until they do, speculation about reasons for delays based on HDVY's PR's is frustrating but meaningless.
Don't forget about LCI. FDA date now overdue. Stock traded down .15 to 5.60 on Friday. (alerted here at $5.07)
Serious congratulations are in order Sheff. Both your track record of picking winners and the short time it took to establish your reputation are quite remarkable.
Thanks and continued success.
So are you in?
FCSC .67 http://www.fibrocellscience.com/
CRL response accepted by FDA today. PDUFA for laViv®, for the treatment of moderate to severe nasolabial folds and wrinkles is June 22, 2011.
Shares traded as high as .79 before falling back to .60 midday.
In the initial submission, FDA panel voted 11-3 on efficacy but 6-8 on safety. FCSC did a follow-up clinical trial (FDA helped in the design) to address safety issues:
“Azficel-T was directly compared to a placebo injection as well as untreated skin in each subject. The study results were consistent with previous clinical studies, while providing a detailed examination of azficel-T activity at the microscopic level after repeated injections,” said James Merritt, M.D., Clinical Advisor to the study and Chief Medical Officer of CBR International Corp., a Colorado based research firm who provided medical advice to Fibrocell during the study. "The study met all expectations, and importantly raised no safety concerns."
13.65 million dollar market cap.
Bad time to be relying on social security benefits in the US of A. Great time to be in the wrinkle-correction biz!
Done.
Just gotta' remember Quirk and his deal from last fall; he agreed to a 5 year muzzle and warrants starting at .25 and moving up from there.
I'm confident that he was shown or saw something in HDVY that reinforced his belief that he was making a good deal.
People leave jobs all the time for a variety of reasons, most of which, out of professional courtesy and protocol, are never disclosed to the public.
What's amazing to me is, what was JBI was doing with all their P2O juice for the past 9 months? If the machine was indeed regularly running, they must have stockpiled a lot of liquid. Surely in that time they explored and attempted to make a commercially viable blend. And if you accept that premise, than hiring on the new guy isn't all that fantastic an omen; after all, we've been told all along that the P2O juice is essentially gas, diesel or something very, very close to it. 9 months later, we get a CC that doesn't state that JBI has a sell-able product.
Why the PPS hit the skids today is IMO a simple reflection of the above. No sales, no contracts, no mention of how much is currently held in the tanks and little insight about the current $$ rate.
Cash is a burnin' at JBI, and it's a race between selling something and dipping into the ugly funding well again.
LCI
Agree fully. LCI took its hits for the last round of dilution. The big boys bought in for $5.00 a share and as much as I hate to admit it, they're better stock pickers than I am, LOL
The floor is in. The risk here is minimal IMO.
FROI- Rain, do you know: does the company sell directly to Merck and receive $$ for all 20,000 units (or more) or does the company make $$ only on the actual amount of Sucanon sold? TIA
LCI $5.06
Whacked down to $5 a share this week after selling 2.5 million shares. Today's close is a mere tick over the share offering price.
http://finance.yahoo.com/news/Lannett-Announces-Closing-of-bw-527986636.html?x=0&.v=1
Expecting a FDA decision for morphine sulfate oral solution on 26 Dec.
http://www.lannett.com/
Nice thought, but given that the only company PRs of material relevance were insider purchases- DR's last stand and Bruce's cheeseburger money, I think that somehow, if insiders were buying, we'd know all about it. Side note: Bruce and company didn't think the 25 million share dilution hit was worth public dissemination.
"glass half full" is ludicrously optimistic IMO given the Conmed news. The single advantage that CTGI once had was the 2-3 year head start on the competition. That was erased with a single PR last week.
Excellent news and post. Let's hope the move from good news to fantastic deals is a short and dramatic one.
Exactly my approach- one big winner out of a basket of 4 or 5 small caps with good stories and your year is made.....just gotta' time the selling a bit better with this one, LOL
LOL, lots of acid gas to be found in the bellies of CTGI investors over the past couple of years.....maybe they can use the patented CCTI process to scrub it into something usable!
What's your point about Piazza? William C. Weldon is the CEO of Johnson and Johnson. What do the 2 men have in common? That's right, neither work for CTGI.
You would have needed to buy at a much higher multiple if you wanted my shares.
Final Word from me: GLTA and good bye.
Thanks Zenos, Degreed and all others who have been here over the long haul. Who knows? Maybe we'll meet again soon under happier conditions.
How's that TA looking now? lol
learn to speak Mandarin
ninja is right- any TA guy or chartist will tell you that without volume, charts are meaningless.
If you think a handful of shares traded translates into meaningful future predictions, you are flat out goofy.
If HDVY or Quest can announce something positive about the urine test, the sooner the better as far as I'm concerned. Market timing might be a factor with puff PRs (and HDVY certainly has had their share), but if the news is substantial, get it out ASAP.
My understanding always was that Piazza and crew were waiting for CTGI to get its financial house in order before assuming any LTC duties. It was, and continues to be a red flag that Piazza has the $$ to fund commercialization of LTC but refuses to actually do so. The obvious question is:
Why wouldn't Piazza throw his money in here?
The obvious answer is:
He wants to get paid. He's a pro, not a dreamchaser.
He can wait and and get the LTC assets for pennies on the dollar in a few months?
Looks like Bruce is the new Don these days- taking all the heat for the ragged state the company finds itself in today.
At least Bruce puts himself in the line of fire. As for CEO Kurtz, he's been no where to be seen since taking the job early this year.
Still offended by the suggestion (at the time) that the company needed a replacement CEO with more hunger and hustle, and the best of his career ahead of him?
Sorry for your pain lostatsea.
Let's put it into some historical context: I was one of a handful of posters who regularly pointed out the faults with the ostrich-style optimism that controlled this board, which only very, very lately has become a tad more realistic.
Any posts I made in the past year and more about the unaccountability of shares, choice of a new CEO, selective PR'ing of material information by insiders, etc were met with derision and denial; a factual discussion of the DD wasn't part of the agenda here.
Any posts that extrinsic made concerning TA and PPS predictions, all of which were ridiculed and yet have come to pass exactly as forecast, were rebutted by the age old, hackneyed cliches about shorting, wanting shares at a lower price, MM manipulation, etc.
the investors here are sure forced to endure the poetical crying. Sheesh. . To the best of my knowledge, there isn't a gun put to anyone's head. Nobody here is forced to endure anything, be it poetical crying or years of unfounded optimism which refuses to acknowledge differing points of view. Everyone knows where the ignore button is and how to use it.
I will note, however, that ninja resigned from his position as assistant moderator before voicing angers repeatedly and while my views have often differed from his in the past, I certainly respect him for recognizing that with power comes influence. And with influence comes responsibility.
Fear of missing the big run has been at the root of the demise of many a good portfolio. I know a lot of true believers in many different companies who read the tea leaves and held all the way down, just because they were afraid to miss the big run.
I've been here for 5 years. In that time I've bought and sold 3 times, which has resulted in 32k freebies. For me, the volume here is too paltry to make this a worthy trading stock, so trading is out unless you are willing to put in your buy/sell order and wait for it to come to you.
That said, the company has a history of issuing less than amazing PRs which goose the price toward the upper end of the trading range. .14-.21 is a pretty nice run in terms of %, so the next time Barnhill PRs a new app for pulling his thumb out of his azz, I'll be trading appropriately.......
woulda, shoulda, coulda on the melanoma app, which always smelt like a gimmick to me.
I agree 100%...but if you bought this with any risk of margin, there's a bridge I'd like to show you.......
Do you have any lowball bids in, just in case? Personally, I'm waiting on the sidelines. Too many other good plays out there now.
There's a real ebb and flow to the frustration level of a HDVY investor. Thanks for the recent reminders about:
1. Quirk and his warrants. This is huge IMO
2. The pipeline here- even if HDVY were to be bought out, isn't the test for breast cancer being developed apart from HDVY, though using their SVM technology?
3. The extreme DD that Quest has to perform before getting 100% behind the urine test and commercializing it
4. The fact that being a secretive, aloof dickhead is Dr Barnhill's public corporate persona
The buy/sell equation here really hasn't changed here too much: Do you believe the urine test is for real or not?
GLTA
I don't think the action since the RS would qualify as "trading".
This thing has been and continues to be dead. Until they release some fins and forward looking PRs, there's no reason to engage with this company.
Like you, I had hoped it would happen in a more timely fashion.
hear hear. Still waiting...was hoping that we'd be trading in the last nice upswing in China small caps, but it looks like that tide might be turning now as well.
Makes one wonder if Liberty has had a look at the drill results we're all waiting to see...
AAA had been trailing behind the other potash juniors, but maybe someone knew something last week
Nov 30, 2010 20:36 ETAllana Potash Corp. Closes $12.39 Million Private Placement With Strategic Investor
TORONTO, ONTARIO--(Marketwire - Nov. 30, 2010) -
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRES
Allana Potash Corp. (TSX VENTURE:AAA) ("Allana" or the "Company"), is pleased to announce that it has closed a non-brokered private placement of 24,300,000 common shares (the "Common Shares") at a price of $0.51 per Common Share (the "Offering Price") for gross proceeds of CAD$12,393,000 pursuant to the TSX Venture Exchange's expedited filing system (the "Offering").
Farhad Abasov, President and CEO of Allana, commented: "We are very pleased to close the strategic financing with Liberty Metals & Mining Holdings, LLC ("LMM"), a subsidiary of Liberty Mutual Group. This financing has allowed us to raise a substantial amount of equity capital at an attractive cost and will fully finance our Ethiopian potash project through the completion of the exploration program and bankable feasibility study. We continue to receive considerable interest from various organizations regarding our Ethiopian potash project and we are free to continue these discussions from a strong position, knowing that we are well financed through the completion of a bankable feasibility study. It is very important to note that LMM is a long-term investor who is committed to assisting Allana when our Company enters the mine construction stage. I would like to welcome Ms. Diana Walters, the President of LMM, to Allana's board. Diana will bring a wealth of experience in equity and debt financing to our potash project."
In accordance with the terms of the Offering, LMM has purchased all of the Common Shares. The Offering Price was based on a 4% premium to the twenty day volume weighted average price of the Common Shares on the TSX Venture Exchange. No finder's fees or any other finder's compensation will be paid in connection with the Offering.
Pursuant to the terms of the Offering, the Company and LMM have entered into an Investor Rights Agreement which gives LMM certain rights, including without limitation, participation and registration rights (in certain circumstances), as well as the right to nominate one director to the board of Allana, provided LMM continues to hold at least 7.5% of Allana's issued and outstanding shares. In addition, subject to certain conditions, LMM shall have the right to participate in any future equity or equity-linked financings by the Company in order to maintain its current ownership in the Company.
Pursuant to the closing of the Offering, LMM now holds approximately 17% of the issued and outstanding shares of the Company and Ms. Diana Walters has been appointed to Allana's board of directors. Ms. Walters is the President of LMM.
The Company plans to use the net proceeds from the Offering to fund a drilling program and feasibility study for the Company's main asset, its Ethiopian potash property in the Danakhil evaporate basin, and for general corporate purposes.
Closing of the financing is subject to receipt of all regulatory approvals, including final approval of the TSX Venture Exchange. The Common Shares issued pursuant to the Offering are subject to a four month and one day statutory hold period, until March 31, 2011.
About Allana Potash Corp.
Allana is a publicly traded corporation with a focus on the acquisition and development of potash assets internationally with its major focus on a previously explored potash property in Ethiopia with Inferred Mineral Resources of 70.3 million tonnes of kainitite mineralization grading 61.7 % kainite and 30.3 million tonnes of sylvinite resource grading 25.4 % sylvite (combined 105,200,000 tonnes with a composite grade of 20.8 % KCl (see News Release dated Sept. 17, 2008). Allana has approximately 143.2 million shares outstanding and trades on the TSX-Venture exchange under the symbol "AAA".
Peter J. MacLean, Ph.D., P. Geo., Allana's Senior VP Exploration, is a Qualified Person as defined under National Instrument 43-101 and has reviewed and approved the technical information presented in this release.
AAA.V cuts a big deal for funding at .51 a share. Thr stock closed at .56 today. Barring a huge political crisis in Ethiopia, which is highly unlikely IMO, this is the most compelling potash play out there in terms of risk/reward.
Nov 30, 2010 20:36 ETAllana Potash Corp. Closes $12.39 Million Private Placement With Strategic Investor
TORONTO, ONTARIO--(Marketwire - Nov. 30, 2010) -
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRES
Allana Potash Corp. (TSX VENTURE:AAA) ("Allana" or the "Company"), is pleased to announce that it has closed a non-brokered private placement of 24,300,000 common shares (the "Common Shares") at a price of $0.51 per Common Share (the "Offering Price") for gross proceeds of CAD$12,393,000 pursuant to the TSX Venture Exchange's expedited filing system (the "Offering").
Farhad Abasov, President and CEO of Allana, commented: "We are very pleased to close the strategic financing with Liberty Metals & Mining Holdings, LLC ("LMM"), a subsidiary of Liberty Mutual Group. This financing has allowed us to raise a substantial amount of equity capital at an attractive cost and will fully finance our Ethiopian potash project through the completion of the exploration program and bankable feasibility study. We continue to receive considerable interest from various organizations regarding our Ethiopian potash project and we are free to continue these discussions from a strong position, knowing that we are well financed through the completion of a bankable feasibility study. It is very important to note that LMM is a long-term investor who is committed to assisting Allana when our Company enters the mine construction stage. I would like to welcome Ms. Diana Walters, the President of LMM, to Allana's board. Diana will bring a wealth of experience in equity and debt financing to our potash project."
In accordance with the terms of the Offering, LMM has purchased all of the Common Shares. The Offering Price was based on a 4% premium to the twenty day volume weighted average price of the Common Shares on the TSX Venture Exchange. No finder's fees or any other finder's compensation will be paid in connection with the Offering.
Pursuant to the terms of the Offering, the Company and LMM have entered into an Investor Rights Agreement which gives LMM certain rights, including without limitation, participation and registration rights (in certain circumstances), as well as the right to nominate one director to the board of Allana, provided LMM continues to hold at least 7.5% of Allana's issued and outstanding shares. In addition, subject to certain conditions, LMM shall have the right to participate in any future equity or equity-linked financings by the Company in order to maintain its current ownership in the Company.
Pursuant to the closing of the Offering, LMM now holds approximately 17% of the issued and outstanding shares of the Company and Ms. Diana Walters has been appointed to Allana's board of directors. Ms. Walters is the President of LMM.
The Company plans to use the net proceeds from the Offering to fund a drilling program and feasibility study for the Company's main asset, its Ethiopian potash property in the Danakhil evaporate basin, and for general corporate purposes.
Closing of the financing is subject to receipt of all regulatory approvals, including final approval of the TSX Venture Exchange. The Common Shares issued pursuant to the Offering are subject to a four month and one day statutory hold period, until March 31, 2011.
About Allana Potash Corp.
Allana is a publicly traded corporation with a focus on the acquisition and development of potash assets internationally with its major focus on a previously explored potash property in Ethiopia with Inferred Mineral Resources of 70.3 million tonnes of kainitite mineralization grading 61.7 % kainite and 30.3 million tonnes of sylvinite resource grading 25.4 % sylvite (combined 105,200,000 tonnes with a composite grade of 20.8 % KCl (see News Release dated Sept. 17, 2008). Allana has approximately 143.2 million shares outstanding and trades on the TSX-Venture exchange under the symbol "AAA".
Peter J. MacLean, Ph.D., P. Geo., Allana's Senior VP Exploration, is a Qualified Person as defined under National Instrument 43-101 and has reviewed and approved the technical information presented in this release.
Yup, a .51 floor sure looks good when compared to the share price a couple of months ago.
Information is leverage- the closer to production he can get AAA, the higher the price for a buy out or JV.
I just added 1.5 terabytes to my home system....set me back about 100 bucks. I wonder what IWEB's gonna' clear with an 80 TB expansion kit.
The "volume" today (7647 shares) was me.... at .17
A K's worth of paint to end the day and make everyone feel a bit richer for the long weekend!
Yeah I noticed that as well when I perused the website. Big list of impressive names to be sure.
Hard to believe that with such an impressive list of clients their revenue could drop so drastically. Did you read the section of the Q that explains the 81% of revenue they received from 2 clients (now 1)?
IMO, corporate name dropping is a bit distasteful, especially given the reality of the obviously paltry amount of biz they actually do with the names on that list.
The dramatic decrease in revenues during the third quarter of 2010 was due primarily to the drop in our orders from our major customer, Shanghai Xin Dian.
A perfect example of the fragility of a company with only 1 or 2 major customers.
We believe the reduction is temporary and the order quantities will be back to normal due to our positive working relationship with Shanghai Xin Dian.
Let's hope so. And let's hope they develop a wider range of revenue streams because this Q demonstrates that even if CLGZ regains its former business relationship with Shanghai Xin Dian, investors will have good reason to be wary here.